323 related articles for article (PubMed ID: 10224129)
1. The activation sequence of thrombospondin-1 interacts with the latency-associated peptide to regulate activation of latent transforming growth factor-beta.
Ribeiro SM; Poczatek M; Schultz-Cherry S; Villain M; Murphy-Ullrich JE
J Biol Chem; 1999 May; 274(19):13586-93. PubMed ID: 10224129
[TBL] [Abstract][Full Text] [Related]
2. Molecular interactions that confer latency to transforming growth factor-beta.
Young GD; Murphy-Ullrich JE
J Biol Chem; 2004 Sep; 279(36):38032-9. PubMed ID: 15208302
[TBL] [Abstract][Full Text] [Related]
3. Thrombospondin binds and activates the small and large forms of latent transforming growth factor-beta in a chemically defined system.
Schultz-Cherry S; Ribeiro S; Gentry L; Murphy-Ullrich JE
J Biol Chem; 1994 Oct; 269(43):26775-82. PubMed ID: 7929413
[TBL] [Abstract][Full Text] [Related]
4. Activation of latent TGF-beta by thrombospondin-1: mechanisms and physiology.
Murphy-Ullrich JE; Poczatek M
Cytokine Growth Factor Rev; 2000; 11(1-2):59-69. PubMed ID: 10708953
[TBL] [Abstract][Full Text] [Related]
5. Augmented binding and activation of latent transforming growth factor-beta by a tryptic fragment of latency associated peptide.
Abe M; Oda N; Sato Y; Shibata K; Yamasaki M
Endothelium; 2002; 9(1):25-36. PubMed ID: 12901358
[TBL] [Abstract][Full Text] [Related]
6. The tryptophan-rich motifs of the thrombospondin type 1 repeats bind VLAL motifs in the latent transforming growth factor-beta complex.
Young GD; Murphy-Ullrich JE
J Biol Chem; 2004 Nov; 279(46):47633-42. PubMed ID: 15342643
[TBL] [Abstract][Full Text] [Related]
7. Latent transforming growth factor-beta complex in Chinese hamster ovary cells contains the multifunctional cysteine-rich fibroblast growth factor receptor, also termed E-selectin-ligand or MG-160.
Olofsson A; Hellman U; Ten Dijke P; Grimsby S; Ichijo H; Morén A; Miyazono K; Heldin CH
Biochem J; 1997 Jun; 324 ( Pt 2)(Pt 2):427-34. PubMed ID: 9182700
[TBL] [Abstract][Full Text] [Related]
8. Regulation of transforming growth factor-beta activation by discrete sequences of thrombospondin 1.
Schultz-Cherry S; Chen H; Mosher DF; Misenheimer TM; Krutzsch HC; Roberts DD; Murphy-Ullrich JE
J Biol Chem; 1995 Mar; 270(13):7304-10. PubMed ID: 7706271
[TBL] [Abstract][Full Text] [Related]
9. Role of carbohydrate structures in the binding of beta1-latency-associated peptide to ligands.
Yang Y; Dignam JD; Gentry LE
Biochemistry; 1997 Sep; 36(39):11923-32. PubMed ID: 9305986
[TBL] [Abstract][Full Text] [Related]
10. A peptide antagonist of thrombospondin-1 promotes abdominal aortic aneurysm progression in the angiotensin II-infused apolipoprotein-E-deficient mouse.
Krishna SM; Seto SW; Jose RJ; Biros E; Moran CS; Wang Y; Clancy P; Golledge J
Arterioscler Thromb Vasc Biol; 2015 Feb; 35(2):389-98. PubMed ID: 25524772
[TBL] [Abstract][Full Text] [Related]
11. Interactions between growth factors and integrins: latent forms of transforming growth factor-beta are ligands for the integrin alphavbeta1.
Munger JS; Harpel JG; Giancotti FG; Rifkin DB
Mol Biol Cell; 1998 Sep; 9(9):2627-38. PubMed ID: 9725916
[TBL] [Abstract][Full Text] [Related]
12. Activation of rat alveolar macrophage-derived latent transforming growth factor beta-1 by plasmin requires interaction with thrombospondin-1 and its cell surface receptor, CD36.
Yehualaeshet T; O'Connor R; Green-Johnson J; Mai S; Silverstein R; Murphy-Ullrich JE; Khalil N
Am J Pathol; 1999 Sep; 155(3):841-51. PubMed ID: 10487979
[TBL] [Abstract][Full Text] [Related]
13. Expression of the type-1 repeats of thrombospondin-1 inhibits tumor growth through activation of transforming growth factor-beta.
Yee KO; Streit M; Hawighorst T; Detmar M; Lawler J
Am J Pathol; 2004 Aug; 165(2):541-52. PubMed ID: 15277228
[TBL] [Abstract][Full Text] [Related]
14. The type 1 repeats of thrombospondin 1 activate latent transforming growth factor-beta.
Schultz-Cherry S; Lawler J; Murphy-Ullrich JE
J Biol Chem; 1994 Oct; 269(43):26783-8. PubMed ID: 7929414
[TBL] [Abstract][Full Text] [Related]
15. The recombinant proregion of transforming growth factor beta1 (latency-associated peptide) inhibits active transforming growth factor beta1 in transgenic mice.
Böttinger EP; Factor VM; Tsang ML; Weatherbee JA; Kopp JB; Qian SW; Wakefield LM; Roberts AB; Thorgeirsson SS; Sporn MB
Proc Natl Acad Sci U S A; 1996 Jun; 93(12):5877-82. PubMed ID: 8650186
[TBL] [Abstract][Full Text] [Related]
16. Effect of LSKL peptide on thrombospondin 1-mediated transforming growth factor β signal activation and liver regeneration after hepatectomy in an experimental model.
Kuroki H; Hayashi H; Nakagawa S; Sakamoto K; Higashi T; Nitta H; Hashimoto D; Chikamoto A; Beppu T; Baba H
Br J Surg; 2015 Jun; 102(7):813-25. PubMed ID: 25866938
[TBL] [Abstract][Full Text] [Related]
17. Specific interaction of oxidized low-density lipoprotein with thrombospondin-1 inhibits transforming growth factor-beta from its activation.
Sakamoto Y; Miyazaki A; Tamagawa H; Wang GP; Horiuchi S
Atherosclerosis; 2005 Nov; 183(1):85-93. PubMed ID: 15907858
[TBL] [Abstract][Full Text] [Related]
18. Structural characterization of the latent complex between transforming growth factor beta 1 and beta 1-latency-associated peptide.
McMahon GA; Dignam JD; Gentry LE
Biochem J; 1996 Jan; 313 ( Pt 1)(Pt 1):343-51. PubMed ID: 8546705
[TBL] [Abstract][Full Text] [Related]
19. Thrombospondin causes activation of latent transforming growth factor-beta secreted by endothelial cells by a novel mechanism.
Schultz-Cherry S; Murphy-Ullrich JE
J Cell Biol; 1993 Aug; 122(4):923-32. PubMed ID: 8349738
[TBL] [Abstract][Full Text] [Related]
20. Two distinct regions of latency-associated peptide coordinate stability of the latent transforming growth factor-beta1 complex.
Walton KL; Makanji Y; Chen J; Wilce MC; Chan KL; Robertson DM; Harrison CA
J Biol Chem; 2010 May; 285(22):17029-37. PubMed ID: 20308061
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
